Cargando…
Ferric carboxymaltose for anemia in Crohn’s disease patients at a tertiary center: A retrospective observational cohort study
BACKGROUND: Although the gastrointestinal tract is the most affected by Crohn’s disease (CD), the condition triggers other consequent manifestations, and iron deficiency anemia (IDA) is one of the most common. Intravenous (IV) iron replacement is currently available through several drugs, such as fe...
Autores principales: | Siqueira, Natália Souza Nunes, Pascoal, Livia Bitencourt, Rodrigues, Bruno Lima, de Castro, Marina Moreira, Martins, Alan Sidnei Corrêa, Araújo, Dante Orsetti Silva, Gomes, Luis Eduardo Miani, Camargo, Michel Gardere, Ayrizono, Maria de Lourdes Setsuko, Leal, Raquel Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198098/ https://www.ncbi.nlm.nih.gov/pubmed/37214580 http://dx.doi.org/10.12998/wjcc.v11.i12.2740 |
Ejemplares similares
-
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019) -
Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019) -
Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients
por: Coope, Andressa, et al.
Publicado: (2017) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015) -
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
por: Seid, Melvin H., et al.
Publicado: (2017)